Sjoerd Bouwmeester1, Thomas P Mast2, Daniëlle C J Keulards2, Anouk G W de Lepper2, Ingeborg H F Herold3, Lukas R Dekker2,4, Frits W Prinzen5, Patrick Houthuizen2. 1. Department of Cardiology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands. sjoerd.bouwmeester@catharinaziekenhuis.nl. 2. Department of Cardiology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands. 3. Department of Anesthesiology and Intensive Care, Catharina Hospital, Eindhoven, The Netherlands. 4. Department of Electrical Engineering, Technical University, Eindhoven, The Netherlands. 5. Department of Physiology, School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Abstract
BACKGROUND: Left ventricular (LV) reverse remodeling has been identified as a strong predictor of long-term survival in patients receiving CRT. Interestingly, CRT induces reverse remodeling in the left atrium (LA) as well. It is currently unknown to what extent LA reverse remodeling is correlated to long-term survival after CRT. This study aims to assess the long-term prognostic value of left atrium (LA) reverse remodeling in patients undergoing cardiac resynchronization therapy (CRT). METHODS: Baseline and 3-months follow-up echocardiograms after CRT implantation were prospectively assessed to determine changes in left ventricular end-systolic volume (LVESV), left ventricular ejection fraction (LVEF), left atrial volume (LAV), and left atrial reservoir strain (LASr). Multivariate Cox regression analysis was performed to identify predictors for long-term survival. RESULTS: In our study population of 99 patients with a mean follow-up of 6.3 ± 2.1 years, 43 patients (43%) reached the end-point of all-cause mortality. More extensive LA reverse remodeling, as measured by a relative increase in LASr, was observed in survivors compared to non-survivors (43 [29-64] % vs. 8 [2-28] %, P < 0.001, respectively). After multivariate analysis, delta LASr remained the only significant predictor of mortality [HR per 5%: 0.90 (0.86-0.95); AUC 0.78 (0.68-0.88)]. CONCLUSION: An increase in LASr is associated with favorable long-term outcome after CRT. The observed clinical importance of LA reverse remodeling after CRT asks for further validation in larger prospective cohorts.
BACKGROUND: Left ventricular (LV) reverse remodeling has been identified as a strong predictor of long-term survival in patients receiving CRT. Interestingly, CRT induces reverse remodeling in the left atrium (LA) as well. It is currently unknown to what extent LA reverse remodeling is correlated to long-term survival after CRT. This study aims to assess the long-term prognostic value of left atrium (LA) reverse remodeling in patients undergoing cardiac resynchronization therapy (CRT). METHODS: Baseline and 3-months follow-up echocardiograms after CRT implantation were prospectively assessed to determine changes in left ventricular end-systolic volume (LVESV), left ventricular ejection fraction (LVEF), left atrial volume (LAV), and left atrial reservoir strain (LASr). Multivariate Cox regression analysis was performed to identify predictors for long-term survival. RESULTS: In our study population of 99 patients with a mean follow-up of 6.3 ± 2.1 years, 43 patients (43%) reached the end-point of all-cause mortality. More extensive LA reverse remodeling, as measured by a relative increase in LASr, was observed in survivors compared to non-survivors (43 [29-64] % vs. 8 [2-28] %, P < 0.001, respectively). After multivariate analysis, delta LASr remained the only significant predictor of mortality [HR per 5%: 0.90 (0.86-0.95); AUC 0.78 (0.68-0.88)]. CONCLUSION: An increase in LASr is associated with favorable long-term outcome after CRT. The observed clinical importance of LA reverse remodeling after CRT asks for further validation in larger prospective cohorts.
Authors: Luigi P Badano; Theodore J Kolias; Denisa Muraru; Theodore P Abraham; Gerard Aurigemma; Thor Edvardsen; Jan D'Hooge; Erwan Donal; Alan G Fraser; Thomas Marwick; Luc Mertens; Bogdan A Popescu; Partho P Sengupta; Patrizio Lancellotti; James D Thomas; Jens-Uwe Voigt Journal: Eur Heart J Cardiovasc Imaging Date: 2018-06-01 Impact factor: 6.875
Authors: Kikuko Obase; Lynn Weinert; Andrew Hollatz; Farhan Farooqui; Joseph D Roberts; Mohammed M Minhaj; Avery Tung; Mark Chaney; Takeyoshi Ota; Valluvan Jeevanandam; Kiyoshi Yoshida; Victor Mor-Avi; Roberto M Lang Journal: Eur Heart J Cardiovasc Imaging Date: 2015-12-28 Impact factor: 6.875
Authors: Maria Vittoria Pitzalis; Massimo Iacoviello; Roberta Romito; Francesco Massari; Brian Rizzon; Giovanni Luzzi; Pietro Guida; Andrea Andriani; Filippo Mastropasqua; Paolo Rizzon Journal: J Am Coll Cardiol Date: 2002-11-06 Impact factor: 24.094
Authors: Keith Wheatley; Natalie Ives; Richard Gray; Philip A Kalra; Jonathan G Moss; Colin Baigent; Susan Carr; Nicholas Chalmers; David Eadington; George Hamilton; Graham Lipkin; Anthony Nicholson; John Scoble Journal: N Engl J Med Date: 2009-11-12 Impact factor: 91.245
Authors: Rafael Kuperstein; Ilan Goldenberg; Arthur J Moss; Scott Solomon; Mikhail Bourgoun; Amil Shah; Scott McNitt; Wojciech Zareba; Robert Klempfner Journal: Circ Heart Fail Date: 2013-12-17 Impact factor: 8.790
Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer Journal: Eur Heart J Date: 2016-05-20 Impact factor: 29.983
Authors: John G Cleland; William T Abraham; Cecilia Linde; Michael R Gold; James B Young; J Claude Daubert; Lou Sherfesee; George A Wells; Anthony S L Tang Journal: Eur Heart J Date: 2013-07-29 Impact factor: 29.983